Logo 1 Logo 2

Clinical Trial Details

Trial ID: L4929
Source ID: NCT02177643
Associated Drug: Diacerein
Title: Effect of Diacerein in the Metabolic Control of Patients With DM Type 2 and Secondary Failure to Metformin
Acronym:
Status: UNKNOWN
Study Results: NO
Results:
Conditions: Diabetes-Related Complications|Diabetes Mellitus, Type 2|Insulin Resistance
Interventions: DRUG: Diacerein|DRUG: Placebo
Outcome Measures: Primary: Fasting Glucose Concentration, Baseline, 12 weeks|Fasting Insulin Concentration, Baseline, 12 weeks|HbA1c - glycated haemoglobin, Baseline, 12 weeks|Inflammatory Activity Profile, TNFα IL6 IL1β C-Reactive Protein (CRP), Baseline, 12 weeks|Lipid Panel, Baseline, 12 weeks|Hepatic Function Panel, Baseline, 12 weeks |
Sponsor/Collaborators: Sponsor: University of Campinas, Brazil | Collaborators: Conselho Nacional de Desenvolvimento Científico e Tecnológico|ANS Pharma
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases: PHASE2
Enrollment: 60
Study Type: INTERVENTIONAL
Study Designs: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT
Start Date: 2013-01
Completion Date:
Results First Posted:
Last Update Posted: 2015-09-17
Locations: Universidade Estadual de Feira de Santana, Feira de Santana, Bahia, Brazil|Centro de Estudos em Diabetes e Hipertensão, Fortaleza, Ceará, Brazil|Universidade Estadual de Campinas, Campinas, São Paulo, Brazil
URL: https://clinicaltrials.gov/show/NCT02177643